Journal ArticleOpen Access
<i>Bifidobacterium infantis</i> treatment promotes weight gain in Bangladeshi infants with severe acute malnutrition
Authors
Author Affiliations
Washington University in St. Louis, International Centre for Diarrhoeal Disease Research, University of Nebraska–Lincoln, LungLife AI (United States), ...
Published InScience Translational Medicine
Year2022
Citations158
Abstract
Disrupted development of the gut microbiota is a contributing cause of childhood malnutrition. Bifidobacterium longum subspecies infantis is a prominent early colonizer of the infant gut that consumes human milk oligosaccharides (HMOs). We found that the absolute abundance of Bifidobacterium infantis is lower in 3- to 24-month-old Bangladeshi infants with severe acute malnutrition (SAM) compared to their healthy age-matched counterparts. A single-blind, placebo-controlled trial (SYNERGIE) was conducted in 2- to 6-month-old Bangladeshi infants with SAM. A commercial U.S. donor–derived B. infantis strain (EVC001) was administered daily with or without the HMO lacto- N -neotetraose for 28 days. This intervention increased fecal B. infantis abundance in infants with SAM, although to levels still 10- to 100-fold lower than in untreated healthy…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.